Evidence map›Paper›PMID 33071798›Full record

ArticleFrontiers in pharmacology2020

Noradrenergic Source of Dopamine Assessed by Microdialysis in the Medial Prefrontal Cortex.

Paola Devoto, Claudia Sagheddu, Michele Santoni, Giovanna Flore, Pierluigi Saba, Marco Pistis, Gian Luigi Gessa

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Anxiety and depression: A top-down, bottom-up model of circuit function.Annals of the New York Academy of Sciences · 2023
    Review
  7. Combined αFrontiers in pharmacology · 2023
    Article
  8. Article
  9. Dopaminergic circuits underlying associative aversive learning.Frontiers in behavioral neuroscience · 2022
    Review
  10. Decreased Brain pH and Pathophysiology in Schizophrenia.International journal of molecular sciences · 2021
    Review
  11. Review
  12. Dopamine in Fear Extinction.Frontiers in synaptic neuroscience · 2021
    Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Paola DevotoSection of Neuroscience and Clinical Pharmacology, Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
Claudia SaghedduSection of Neuroscience and Clinical Pharmacology, Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
Michele SantoniSection of Neuroscience and Clinical Pharmacology, Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
Giovanna FloreDepartment of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
Pierluigi SabaSection of Neuroscience and Clinical Pharmacology, Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
Marco PistisSection of Neuroscience and Clinical Pharmacology, Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
Gian Luigi Gessa"Guy Everett" Laboratory, University of Cagliari, Cagliari, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previous results indicate that dopamine (DA) release in the medial prefrontal cortex (mPFC) is modified by α

Indexed as

D2 receptor drugdopamine-norepinephrine interactionneuronal activitynoradrenergic denervationnorepinephrine transporterventral tegmental area

Identifiers

PMID33071798
PMCPMC7538903

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.